Headquarters
33 ARCH ST, 32ND FL, STE 3201, BOSTON, MA 02110-1473, US
BOSTON, MA, US
ARGENX US, INC
From the company
argenx is a global immunology biotech company that co-creates entrepreneurial science, bringing academic discovery, clinical insight, and patient experience together to develop medicines for severe autoimmune diseases. Its approved immunology therapies include VYVGART (efgartigimod) and VYVGART Hytrulo, and it is investigating efgartigimod, empasiprubart, and adimanebart across diseases such as myasthenia gravis, CIDP, ITP, CMS, and SMA.
Products & services offered
Facilities
Send your requirements
Quantities, certifications, and timing.